Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

KROS – keros therapeutics, inc. - common stock (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
KROS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/11
04:39 pm
kros
Form 4 Keros Therapeutics, Inc. For: Mar 09 Filed by: Newton Charles W.
Medium Report
Form 4 Keros Therapeutics, Inc. For: Mar 09 Filed by: Newton Charles W.
Report
3/11
04:37 pm
kros
Form 3 Keros Therapeutics, Inc. For: Mar 09 Filed by: Newton Charles W.
Medium Report
Form 3 Keros Therapeutics, Inc. For: Mar 09 Filed by: Newton Charles W.
Report
3/11
04:34 pm
kros
Form 4 Keros Therapeutics, Inc. For: Mar 09 Filed by: BIENAIME JEAN JACQUES
Medium Report
Form 4 Keros Therapeutics, Inc. For: Mar 09 Filed by: BIENAIME JEAN JACQUES
Report
3/9
08:01 am
kros
Form 8-K Keros Therapeutics, Inc. For: Mar 09
Low Report
Form 8-K Keros Therapeutics, Inc. For: Mar 09
Report
3/4
04:09 pm
kros
Form 8-K Keros Therapeutics, Inc. For: Mar 04
High Report
Form 8-K Keros Therapeutics, Inc. For: Mar 04
Report
3/4
04:08 pm
kros
Form S-8 Keros Therapeutics, Inc.
High Report
Form S-8 Keros Therapeutics, Inc.
Report
3/4
04:04 pm
kros
Form 10-K Keros Therapeutics, Inc. For: Dec 31
High Report
Form 10-K Keros Therapeutics, Inc. For: Dec 31
Report
3/4
04:02 pm
kros
Form 8-K Keros Therapeutics, Inc. For: Mar 04
High Report
Form 8-K Keros Therapeutics, Inc. For: Mar 04
Report
2/26
04:30 pm
kros
Form 4 Keros Therapeutics, Inc. For: Feb 24 Filed by: Lerner Lorena Raquel
Medium Report
Form 4 Keros Therapeutics, Inc. For: Feb 24 Filed by: Lerner Lorena Raquel
Report
2/26
04:30 pm
kros
Form 4 Keros Therapeutics, Inc. For: Jan 05 Filed by: Cho Esther
Medium Report
Form 4 Keros Therapeutics, Inc. For: Jan 05 Filed by: Cho Esther
Report
2/26
04:27 pm
kros
Form 4 Keros Therapeutics, Inc. For: Feb 24 Filed by: Seehra Jasbir
Medium Report
Form 4 Keros Therapeutics, Inc. For: Feb 24 Filed by: Seehra Jasbir
Report
2/26
04:27 pm
kros
Form 4 Keros Therapeutics, Inc. For: Feb 24 Filed by: Regnante Keith
Medium Report
Form 4 Keros Therapeutics, Inc. For: Feb 24 Filed by: Regnante Keith
Report
2/26
04:03 pm
kros
Form 8-K Keros Therapeutics, Inc. For: Feb 20
Medium Report
Form 8-K Keros Therapeutics, Inc. For: Feb 20
Report
2/20
04:15 pm
kros
Form 4 Keros Therapeutics, Inc. For: Feb 18 Filed by: Lerner Lorena Raquel
Medium Report
Form 4 Keros Therapeutics, Inc. For: Feb 18 Filed by: Lerner Lorena Raquel
Report
2/20
04:15 pm
kros
Form 4 Keros Therapeutics, Inc. For: Feb 18 Filed by: Cho Esther
Medium Report
Form 4 Keros Therapeutics, Inc. For: Feb 18 Filed by: Cho Esther
Report
2/20
04:15 pm
kros
Form 4 Keros Therapeutics, Inc. For: Feb 19 Filed by: Seehra Jasbir
Medium Report
Form 4 Keros Therapeutics, Inc. For: Feb 19 Filed by: Seehra Jasbir
Report
2/20
04:15 pm
kros
Form 4 Keros Therapeutics, Inc. For: Feb 18 Filed by: Regnante Keith
Medium Report
Form 4 Keros Therapeutics, Inc. For: Feb 18 Filed by: Regnante Keith
Report
2/18
04:02 pm
kros
Form 8-K Keros Therapeutics, Inc. For: Feb 18
Low Report
Form 8-K Keros Therapeutics, Inc. For: Feb 18
Report
2/17
05:17 pm
kros
Form SCHEDULE 13G/A Keros Therapeutics, Inc. Filed by: ExodusPoint Capital Management, LP
Low Report
Form SCHEDULE 13G/A Keros Therapeutics, Inc. Filed by: ExodusPoint Capital Management, LP
Report
2/17
04:53 pm
kros
Form SCHEDULE 13G/A Keros Therapeutics, Inc. Filed by: Madison Avenue Partners, LP
Low Report
Form SCHEDULE 13G/A Keros Therapeutics, Inc. Filed by: Madison Avenue Partners, LP
Report
2/17
04:16 pm
kros
Form SCHEDULE 13G/A Keros Therapeutics, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
Low Report
Form SCHEDULE 13G/A Keros Therapeutics, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
Report
2/17
04:07 pm
kros
Form SCHEDULE 13G/A Keros Therapeutics, Inc. Filed by: D. E. SHAW & CO, L.P.
Low Report
Form SCHEDULE 13G/A Keros Therapeutics, Inc. Filed by: D. E. SHAW & CO, L.P.
Report
1/30
02:17 pm
kros
Form SCHEDULE 13G/A Keros Therapeutics, Inc. Filed by: VANGUARD GROUP INC
Low Report
Form SCHEDULE 13G/A Keros Therapeutics, Inc. Filed by: VANGUARD GROUP INC
Report
1/9
04:17 pm
kros
Form 8-K Keros Therapeutics, Inc. For: Jan 09
Low Report
Form 8-K Keros Therapeutics, Inc. For: Jan 09
Report
1/9
04:15 pm
kros
Form 4 Keros Therapeutics, Inc. For: Jan 07 Filed by: Seehra Jasbir
Low Report
Form 4 Keros Therapeutics, Inc. For: Jan 07 Filed by: Seehra Jasbir
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2026, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0